Financhill
Back

Seres Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
43

MCRB
Seres Therapeutics

Last Price:
0.80
Seasonality Move:
-5.38%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Seres Therapeutics Price Quote

$0.80
+0.00 (+-2.66%)
(Updated: November 5, 2024 at 3:29 AM ET)

Seres Therapeutics Key Stats

Sell
43
Seres Therapeutics (MCRB) is a Sell

Day range:
$0.79 - $0.85
52-week range:
$0.54 - $2.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.87
P/B ratio:
0%

Volume:
1.5M
Avg. volume:
3.9M
1-year change:
-38.84%
Market cap:
$120.6M
Revenue:
$126.3M
EPS:
$-1.18

How Much Does Seres Therapeutics Make?

Data Unavailable

Is Seres Therapeutics Growing As A Company?

Data Unavailable

Seres Therapeutics Stock Price Performance

What Is Seres Therapeutics 52-Week High & Low?

Seres Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Seres Therapeutics?

Is Seres Therapeutics Cash Flow Positive?

  • What Is MCRB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$181.8M
  • What Is Seres Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $26.6M
  • What Is Seres Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.4M

Seres Therapeutics Return On Invested Capital

Data Unavailable

Seres Therapeutics Earnings Date & Stock Price

Seres Therapeutics Competitors

Seres Therapeutics Dividend Yield

Seres Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 25.52%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 3.89
Upside from Last Price: 389.75%

Major Shareholders

  • How many MCRB shares are owned by institutional investors?
    145.5M MCRB shares are owned by institutional investors
  • How many MCRB shares are owned by insiders?
    1.5M MCRB shares are owned by insiders